CDX-2 should be included in the work-up of patients with lung metastases from unknown primary

Ann Oncol. 2004 Dec;15(12):1850. doi: 10.1093/annonc/mdh482.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / secondary*
  • Biomarkers, Tumor / analysis*
  • CDX2 Transcription Factor
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / pathology*
  • Diagnosis, Differential
  • Homeodomain Proteins / analysis*
  • Homeodomain Proteins / biosynthesis
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / secondary*
  • Male
  • Middle Aged
  • Neoplasms, Unknown Primary / diagnosis*
  • Trans-Activators / analysis*
  • Trans-Activators / biosynthesis

Substances

  • Biomarkers, Tumor
  • CDX2 Transcription Factor
  • Homeodomain Proteins
  • Trans-Activators